Anondita Medicare IPO

₹1,37,000/1,000 shares

Minimum Investment

IPO Details

Open Date

22 Aug 25

Close Date

26 Aug 25

Minimum Investment

₹1,37,000

Lot Size

1,000

Price Range

₹137 to ₹145

Listing Exchange

NSE

Issue Size

₹69.50 Cr

Listing Date

01 Sep 25

Open Free Demat Account

Anondita Medicare IPO Timeline

Bidding Start

22 Aug 25

Bidding Ends

26 Aug 25

Allotment Finalisation

28 Aug 25

Refund Initiation

29 Aug 25

Demat Transfer

29 Aug 25

Listing

01 Sep 25

Anondita Medicare Limited

Founded in March 2024, Anondita Medicare Limited specializes in manufacturing flavored male condoms, with its flagship brand, “COBRA,” producing 562 million units annually. Based in Noida, Uttar Pradesh, the company exports to markets across Southeast Asia, Africa, and the Middle East. Partnering with global health organisations, NGOs, and governments, it actively supports family planning and public health initiatives. With a strong distribution network, Anondita Medicare ensures timely delivery through wholesalers, retailers, and e-commerce platforms, while maintaining close ties with government health programs to supply essential medical products effectively.

Anondita Medicare Limited IPO Overview

Anondita Medicare Limited is launching an IPO worth ₹69.50 crore through a book-building process, entirely comprising a fresh issue of 0.48 crore shares. The IPO opens for subscription on August 22, 2025, and closes on August 26, 2025, with allotment expected by August 28, 2025. The shares are set to list on NSE SME around September 1, 2025. The price band is ₹137 to ₹145 per share, with a retail lot size of 1,000 shares requiring a minimum investment of ₹2,74,000. HNIs must apply for at least 3 lots, amounting to ₹4,35,000. Narnolia Financial Services Ltd. serves as the book running lead manager, Maashitla Securities Pvt. Ltd. as registrar, and Mansi Share & Stock Broking Pvt. Ltd. as market maker.

Anondita Medicare Limited IPO Details

Particulars	Details
IPO Date	22 August 2025 to 26 August 2025
Listing Date	1 September 2025
Face Value	₹10 per share
Issue Price Band	₹137 to ₹145 per share
Lot Size	1,000 Shares
Total Issue Size	47,93,000 shares (aggregating up to ₹69.50 Cr)
Fresh Issue	47,93,000 shares (aggregating up to ₹69.50 Cr)
Offer for Sale	NA
Issue Type	Bookbuilding IPO
Listing At	NSE SME
Share Holding Pre Issue	1,32,93,618 shares
Share Holding Post Issue	1,80,86,618 shares
Market Maker Portion	2,70,000 shares

Anondita Medicare Limited IPO Reservation

Investor Category	Shares Offered
Market Maker	2,70,000 (5.63%)
QIB	22,58,000 (47.11%)
NII (HNI)	6,81,000 (14.21%)
Retail	15,84,000 (33.05%)
Total	47,93,000 (100%)

Anondita Medicare Limited IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	2	2,000	₹2,90,000
Retail (Max)	2	2,000	₹2,90,000
S-HNI (Min)	3	3,000	₹4,35,000
S-HNI (Max)	6	6,000	₹8,70,000
B-HNI (Min)	7	7,000	₹10,15,000

Anondita Medicare Limited IPO Promoter Holding

Shareholding Status	Percentage
Pre-Issue	83.95%
Post-Issue	61.71%

Anondita Medicare Limited IPO Valuation Overview

KPI	Value
EPS	12.35 (Pre IPO), 9.08 (Post IPO)
Price/Earnings (P/E) Ratio	11.74 (Pre IPO), 15.98 (Post IPO)
Return on Net Worth (RoNW)	41.71%
Net Asset Value (NAV)	21.32 per share
Return on Equity	41.71%
Return on Capital Employed (ROCE)	37.42%
EBITDA Margin	33.32%
PAT Margin	21.32%
Debt to Equity Ratio	0.70

Objectives of the Proceeds

Funding capital expenditure for purchase of new equipment – ₹60 million

Funding working capital requirements – ₹350 million

General corporate purposes and potential acquisitions

Key Financials (in ₹ Crore)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	78.27	42.92	37.80
Revenue	77.13	46.56	36.14
Profit After Tax	16.42	3.84	0.35
Reserves and Surplus	24.58	10.39	6.55
Total Borrowings	27.39	24.01	22.66

SWOT Analysis of Anondita Medicare IPO

Strength and Opportunities

Experienced and significant condom manufacturer in India with high brand recognition.
Well-recognized in North India, providing a competitive regional advantage.
Offers a diverse range of products catering to multiple consumer segments.
Strong export network in Southeast Asia, Africa, and Middle East.
Collaborates with NGOs and governments for public health initiatives.

Risks and Threats

Reliance on domestic market could limit diversification potential.
Intense competition from established global and local condom manufacturers.
Regulatory changes in health product standards may impact operations
Supply chain disruptions could affect timely delivery to international markets.
Dependence on limited flagship product “COBRA” may limit revenue diversification.

Explore IPO Opportunities

Explore our comprehensive IPO pages to stay updated on the latest trends and insights.

Upcoming SME IPOs

Current SME IPOs

Closed SME IPOs

About Anondita Medicare Limited

Anondita Medicare IPO Strengths

A leading and well-established condom manufacturer in India.

Strong brand presence and recognition across North India.

Provides a wide and varied range of products.

Peer Comparison

Company Name	EPS (Basic)	EPS (Diluted)	NAV per Share (Rs)	P/E (x)	RoNW (%)	P/BV Ratio
Anondita Medicare Limited	9.60	9.60	21.32	–	38.10	–
Cupid Ltd.	1.52	1.52	12.75	110.38	11.96	13.92

How to apply IPO with HDFC SKY?

Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.

1Login to your HDFC SKY Account

2Select Issue

3Enter Number of Lots and your Price.

4Enter UPI ID

5Complete Transaction on Your UPI App